Infinity Pharma 3Q Loss Narrows On Payments
Stock quotes in this article:
INFI
CAMBRIDGE, Mass. (AP) Infinity Pharmaceuticals Inc. said Monday its third-quarter loss narrowed on a boost in payments from its partnership with Purdue Pharmaceutical Products LP and Mundipharma International Corp.
The company lost $9.3 million, or 36 cents per share, compared with a loss of $12.4 million, or 63 cents per share, during the same period a year prior. Revenue surged to $13.8 million from $2.5 million. Analysts polled by Thomson Reuters expected a loss of 44 cents per share on revenue of $12.4 million. Infinity has several compounds in development, aimed at various types of cancer. Shares of Infinity added 5 cents to $5.78 in morning trading Tuesday.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,464.40 | 1,110.63 | 2,176.05 | 32.79 |
Oil *
77.05
|
|
UP
30.69
|
UP
4.98
|
UP
6.87
|
DOWN
0.38
|
10 Yr
3.28%
SPDR Gold
116.62
|
|
+0.29%
|
+0.45%
|
+0.32%
|
-1.15%
|
Data delayed 20 minutes |














